These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3128786)

  • 1. Proteolytic requirements for thrombin activation of anti-hemophilic factor (factor VIII).
    Pittman DD; Kaufman RJ
    Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2429-33. PubMed ID: 3128786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of individual tyrosine sulfation sites within factor VIII required for optimal activity and efficient thrombin cleavage.
    Michnick DA; Pittman DD; Wise RJ; Kaufman RJ
    J Biol Chem; 1994 Aug; 269(31):20095-102. PubMed ID: 8051097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The structural integrity of anion binding exosite I of thrombin is required and sufficient for timely cleavage and activation of factor V and factor VIII.
    Bukys MA; Orban T; Kim PY; Beck DO; Nesheim ME; Kalafatis M
    J Biol Chem; 2006 Jul; 281(27):18569-80. PubMed ID: 16624813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The factor V B-domain provides two functions to facilitate thrombin cleavage and release of the light chain.
    Marquette KA; Pittman DD; Kaufman RJ
    Blood; 1995 Oct; 86(8):3026-34. PubMed ID: 7579396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity.
    Eaton D; Rodriguez H; Vehar GA
    Biochemistry; 1986 Jan; 25(2):505-12. PubMed ID: 3082357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of factor VIII inactivation by human antibodies. III. Proteolytic cleavage of factor VIII:C and C antigen by thrombin.
    Lazarchick J; Ashby MA; Lazarchick JJ; Sens DA
    Ann Clin Lab Sci; 1985; 15(6):482-7. PubMed ID: 3933404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of thrombin on human factor VIII. Cleavage of the factor VIII procoagulant protein during activation.
    Hoyer LW; Trabold NC
    J Lab Clin Med; 1981 Jan; 97(1):50-64. PubMed ID: 6778941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of von Willebrand factor on activation of factor VIII by factor Xa.
    Koedam JA; Hamer RJ; Beeser-Visser NH; Bouma BN; Sixma JJ
    Eur J Biochem; 1990 Apr; 189(2):229-34. PubMed ID: 2110896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A2 domain of human recombinant-derived factor VIII is required for procoagulant activity but not for thrombin cleavage.
    Pittman DD; Millenson M; Marquette K; Bauer K; Kaufman RJ
    Blood; 1992 Jan; 79(2):389-97. PubMed ID: 1730084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. von Willebrand factor is a cofactor for thrombin-catalyzed cleavage of the factor VIII light chain.
    Hill-Eubanks DC; Lollar P
    J Biol Chem; 1990 Oct; 265(29):17854-8. PubMed ID: 2120219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a genetically engineered inactivation-resistant coagulation factor VIIIa.
    Pipe SW; Kaufman RJ
    Proc Natl Acad Sci U S A; 1997 Oct; 94(22):11851-6. PubMed ID: 9342326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of the 268-282 region of glycoprotein Ibalpha with the heparin-binding site of thrombin inhibits the enzyme activation of factor VIII.
    De Cristofaro R; De Filippis V
    Biochem J; 2003 Jul; 373(Pt 2):593-601. PubMed ID: 12689334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteolysis at Arg740 facilitates subsequent bond cleavages during thrombin-catalyzed activation of factor VIII.
    Newell JL; Fay PJ
    J Biol Chem; 2007 Aug; 282(35):25367-75. PubMed ID: 17595160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of des-(741-1668)-factor VIII, a single-chain factor VIII variant with a fusion site susceptible to proteolysis by thrombin and factor Xa.
    Donath MJ; de Laaf RT; Biessels PT; Lenting PJ; van de Loo JW; van Mourik JA; Voorberg J; Mertens K
    Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):49-55. PubMed ID: 7492334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential proteolytic activation of factor VIII-von Willebrand factor complex by thrombin.
    Hill-Eubanks DC; Parker CG; Lollar P
    Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6508-12. PubMed ID: 2505252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Glu113Ala mutation within a factor VIII Ca2+-binding site enhances cofactor interactions in factor Xase.
    Wakabayashi H; Su YC; Ahmad SS; Walsh PN; Fay PJ
    Biochemistry; 2005 Aug; 44(30):10298-304. PubMed ID: 16042406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the intrinsic factor X activating complex by protein S: evidence for a specific binding of protein S to factor VIII.
    Koppelman SJ; Hackeng TM; Sixma JJ; Bouma BN
    Blood; 1995 Aug; 86(3):1062-71. PubMed ID: 7620160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor VIII: structure and function in blood clotting.
    Chavin SI
    Am J Hematol; 1984 Apr; 16(3):297-306. PubMed ID: 6424437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cysteamine enhances the procoagulant activity of Factor VIII-East Hartford, a dysfunctional protein due to a light chain thrombin cleavage site mutation (arginine-1689 to cysteine).
    Aly AM; Arai M; Hoyer LW
    J Clin Invest; 1992 May; 89(5):1375-81. PubMed ID: 1569180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced thrombin sensitivity of a factor VIII-heparin cofactor II hybrid.
    Voorberg J; van Stempvoort G; Bos JM; Mertens K; van Mourik JA; Donath MJ
    J Biol Chem; 1996 Aug; 271(35):20985-8. PubMed ID: 8702860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.